{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:39:37Z","timestamp":1791725977734,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.psychres.2018.09.014","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:27:47Z","timestamp":1537223267000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antipsychotics and cardiovascular risk: A case\/non-case study"],"prefix":"10.1016","volume":"270","author":[{"given":"Luis H. Mart\u00edn","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario Sanz","family":"Fadrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana P\u00e9rez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S\u00e1inz","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Trece\u00f1o","family":"Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar Garc\u00eda","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2018.09.014_bib0001","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.psychres.2018.09.014_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4088\/JCP.v60n0402","article-title":"The distribution of body mass index among individuals with and without schizophrenia","volume":"60","author":"Allison","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","article-title":"Novel statistical tools for monitoring the safety of marketed drugs","volume":"82","author":"Almenoff","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2018.09.014_bib0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eurpsy.2005.07.006","article-title":"Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence","volume":"21","author":"Arango","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eurpsy.2010.09.001","article-title":"Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study","volume":"27","author":"Bobes","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0006","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2125.2011.04043.x","article-title":"The association between antipsychotic agents and the risk of myocardial infarction: a systematic review","volume":"72","author":"Brauer","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0007","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00002018-200225010-00002","article-title":"Case-population studies in pharmacoepidemiology","volume":"25","author":"Capell\u00e0","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v65n0519","article-title":"Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada","volume":"65","author":"Curkendall","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0010","doi-asserted-by":"crossref","first-page":"a1227","DOI":"10.1136\/bmj.a1227","article-title":"Exposure to antipsychotics and risk of stroke: self-controlled case series study","volume":"337","author":"Douglas","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2018.09.014_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JCP.0b013e3182485888","article-title":"Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics","volume":"32","author":"Ellingrod","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0012","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0013","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jpsychires.2013.07.011","article-title":"Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies","volume":"47","author":"Fan","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2018.09.014_bib0014","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2018.09.014_bib0015","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0016","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.149.9.1189","article-title":"Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects","volume":"149","author":"Goff","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0017","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, torsade de pointes and sudden death","volume":"62","author":"Haddad","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2018.09.014_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pds.1881","article-title":"Prescription refill records as a screening tool to identify antidepressant non-adherence","volume":"19","author":"Hansen","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0019","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","article-title":"Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data","volume":"325","author":"Hennessy","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2018.09.014_bib0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","article-title":"Atypical antipsychotics and risk of cerebrovascular accidents","volume":"161","author":"Herrmann","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psychres.2018.09.014_bib0022","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1997.00440380123013","article-title":"Torsade de pointes and low-dose oral haloperidol","volume":"157","author":"Jackson","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.psychres.2018.09.014_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/647476","article-title":"Risk of mortality (including sudden cardiac death) and major cardiovascular events in users of olanzapine and other antipsychotics: a study with the General Practice Research Database","volume":"2013","author":"Jones","year":"2013","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0024","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.nmd.0000221177.51089.7d","article-title":"Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness","volume":"194","author":"Kreyenbuhl","year":"2006","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2018.09.014_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/bjp.182.1.31","article-title":"Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980\u20131998","volume":"182","author":"Lawrence","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0026","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2018.09.014_bib0027","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/schbul\/19.3.551","article-title":"Minor physical anomalies in schizophrenia and mood disorders","volume":"19","author":"Lohr","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.09.014_bib0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40264-015-0351-3","article-title":"An empirical approach to explore the relationship between measures of disproportionate reporting and relative risks from analytical studies","volume":"39","author":"Maci\u00e1 Mart\u00ednez","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0029","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia","volume":"161","author":"Marder","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2125.2001.01292.x","article-title":"Involvement of multiple human cytochromes P450 in the liver microsomal metabollism of astemizole and a comparison with terfenadine","volume":"51","author":"Matsumoto","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0031","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","article-title":"Adverse cardiac effects associated with clozapine","volume":"25","author":"Merrill","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.09.014_bib0033","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","article-title":"Torsades de pointes occurring in association with terfenadine use","volume":"264","author":"Monahan","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2018.09.014_bib0034","first-page":"495","article-title":"Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care","volume":"57","author":"Mundet-Tudur\u00ed","year":"2013","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.psychres.2018.09.014_bib0035","first-page":"765","article-title":"Disorders of cardiac repolarization: the long QT syndromes","volume":"vol. 2","author":"Murray","year":"2004"},{"key":"10.1016\/j.psychres.2018.09.014_bib0036","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/070674370605100803","article-title":"The metabolic effects of antipsychotic medications","volume":"51","author":"Newcomer","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0037","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacol. Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0038","doi-asserted-by":"crossref","first-page":"e81208","DOI":"10.1371\/journal.pone.0081208","article-title":"Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe","volume":"8","author":"Raschi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2018.09.014_bib0039","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/106002809703100712","article-title":"Fatal cardiac event following initiation of risperidone therapy","volume":"31","author":"Ravin","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.psychres.2018.09.014_bib0040","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","article-title":"Antipsychotics and the risk of sudden cardiac death","volume":"58","author":"Ray","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2018.09.014_bib0041","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death","volume":"75","author":"Ray","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2018.09.014_bib0042","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden cardiac death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2018.09.014_bib0043","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2018.09.014_bib0044","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2018.09.014_bib0045","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2018.09.014_bib0046","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"Van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2018.09.014_bib0047","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00003495-199447010-00008","article-title":"Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders","volume":"47","author":"Wiseman","year":"1994","journal-title":"Drugs"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117321807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117321807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:30:01Z","timestamp":1759037401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117321807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"alternative-id":["S0165178117321807"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.09.014","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics and cardiovascular risk: A case\/non-case study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}